Issue link: https://viewer.e-digitaledition.com/i/746097
" An underlying cause of the chronic abdominal pain suffered by IBS patients is the abnormal increase in pain signals being sent from the gastrointestinal tract to the brain. In particular, low- threshold mechanical events within the gastrointestinal tract are often perceived as painful by IBS patients. We have discovered that Na v 1.1 plays a key role in this pathological pain signal. Therefore, inhibiting this channel on nociceptors that innervate the gastrointestinal tract is a key step in blocking mechanical pain at its source." « PROFESSOR STUART BRIERLEY, PhD, HEAD OF THE VISCERAL PAIN RESEARCH GROUP AT FLINDERS UNIVERSITY AND THE SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE sodium channels that had been looked at, Na v 1.1 hadn't received much attention. The fact that these spiders have evolved toxins to interact with this channel piqued our interest and made us think that this channel was playing a more important role in pain sensation than people previously thought." Taking their investigation one step further, researchers injected the Hm1a toxin into the hindquarters of mice to determine what type of pain response was elicited. The Hm1a toxins activated nerve fi bers that generate signals associated with a type of pain endemic to IBS su erers. "Our study shows that Na v 1.1 plays a critical role in transmitting infor- mation about mechanical pain to the brain," says Professor Glenn King, a co-lead author of the study and National Health and Medical Research Council Principal Research Fellow at the Institute for Molecular Bioscience in Brisbane, Australia. "Mechanical pain is the pain experienced, for example, if you accidentally hit your fi nger with a hammer, and it is also the type of gut pain experienced by people with IBS." Using a preclinical mouse model of IBS, in which gut-nerve preparations from healthy mice and mice with chronic visceral hypersensitivity were exposed to Hm1a toxins, researchers were able to confi rm that Na v 1.1 activation does play an important role in transmitting pain signals from the gut to the central nervous system. PATH TO TREATMENT Examining whether or not Na v 1.1's activity is enhanced in the presence of an injury, such as gut infl ammation, may be the focus of additional investigation. In a follow-up collaborative e ort, King and Brierley have also developed Na v 1.1 inhibitors that may form the basis for future phar- macologic agents. "We have one lead molecule already [a spider-venom peptide] that is proving highly e¦ cacious in reducing mechanical pain in a mouse model of IBS," King says. "We hope to publish a paper on this work very soon." ■ SPECIAL CLINICAL SECTION: GASTROENTEROLOGY 1 7

